The Wilder lab aims to prevent immune-mediated adverse side effects associated with cytokine therapy by understanding innate immune regulation and developing dynamically controlled therapies.
Basic and translational research of treatment resistance in cancers of the nervous system using high throughput functional genomics and epigenetic engineering approaches.
Our group develops and applies advances in synthetic biology to better understand biological systems and then to re-engineer these systems to tackle disease.
We study the origins of clonal blood disorders with focus on developmental hematopoiesis and forces driving clonal competition in the context of inherited cancer predisposition conditions.
We use synthetic biology and high-throughput functional genetic screens to understand antigen presentation and T-cell recognition in the context of cancer and other diseases.
Mentorship Development:
10-11/2023 - UCSF Inclusive Mentor/Manager Training
11/2024 - The 4 Touchstones of a High-Functioning Mentoring Relationship
